The majority of HER2-positive tumors are strongly positive for HER3 [18], which is also seen in mouse models of breast cancers, where high expression of HER2 is commonly associated with activated and overexpressed HER3 [23]. The gene discussed is ERBB2; the disease is breast carcinoma.